Latest news with #seminar
Forbes
2 days ago
- General
- Forbes
How To Unlock True Inclusion Through Open-Ended Questions And Allyship
We've all been there: in a leadership training session, a sales workshop, or a communications seminar, learning the undeniable power of open-ended questions. Most seasoned leaders intellectually grasp their importance. Yet, in practice, a significant gap often emerges between what we should be doing and what we're actually doing. This disconnect is a silent saboteur of genuine inclusion and effective allyship. Our brains are hardwired for certainty. When faced with a knowledge gap, our default is to fill it with assumptions based on what we think we already know. This innate tendency stifles curiosity and, critically, prevents us from asking the very questions that could bridge those gaps. Allies, however, consciously resist this default. They pivot to a curious mindset, intentionally peppering their interactions with open-ended questions to truly learn about their teams and foster deeper understanding. Beyond the "Oulds": The Art of Asking Open-ended questions are typically characterized by their starting words: "what" or "how." They rarely begin with helping verbs like "are," "do," "could," "should," or "would." In fact, allies often steer clear of "ould" words altogether. These can often be perceived as condescending, disguising advice within a seemingly innocuous question. The golden rule of effective questioning is simple: never ask a question you already know the answer to, or one you're not genuinely interested in hearing the response to. Doing so creates more harm than good, eroding trust and undermining your efforts at allyship. Consider a simple exercise I use in my allyship programs: pairing individuals and asking one to draw a house, while the other asks questions to learn more about it. Even after instruction on the benefits of open-ended questions, most participants unfortunately default to closed-ended queries: "Is it a ranch? Does it have multiple stories? Are there trees?" These questions rarely provide enough detail to accurately visualize the house. In contrast, a few well-placed open-ended questions – "What type of house is it? How many stories does it have? What does the landscaping look like?" – typically provide enough context for a remarkably similar rendering. The lesson is clear: open-ended questions promote clarity. Without clarity, allies risk being out of sync. You might genuinely be trying to help, but by asking assumption-based questions, you're likely missing the mark, and potentially even reinforcing biases rather than fostering inclusion. Listening to Learn: Your Allyship Compass At its core, allyship is about asking questions and, more importantly, listening. When we speak, we often hear only what we already think we know. When we truly listen, however, we open ourselves up to learning something new, to uncovering perspectives we hadn't considered. If you're unsure which allyship role resonates most with you, start with asking questions. I keep a few key questions in my back pocket as an ally. These aren't meant to be a script, but rather a compass to navigate curious conversations when you feel stuck or unsure what to say or do. The key is to stay genuinely curious, even if just for a little longer, because on the other side of that curious conversation lies learning and growth. Consider these: Dave Moerlein, author of The Safety Effect, offers invaluable questions for leaders engaging with new team members. These demonstrate a proactive commitment to understanding and supporting new hires, fostering inclusion from day one: Embracing Vulnerability for Deeper Connection Now, think about your own team. What do you truly know about them beyond their job titles and tasks? What do you wish you knew? Take a page from Dave's book. In your next one-on-one meeting, dedicate time to exploring their goals, aspirations, and even their expectations for you as a leader. You might feel a pang of fear about what they might say. But consider this: if you're afraid they might be thinking about these questions, it's highly likely they already are. Asking invites them to share, opening the door for deeper connection and trust. Model vulnerability by sharing a bit about yourself in return. This isn't always comfortable. It might feel like doing it afraid. But the results – stronger relationships, deeper understanding, and a more genuinely inclusive environment where everyone feels seen and heard – are profoundly worth it. True allyship begins with the courage to ask and the humility to listen. Asking open-ended questions is a crucial, yet often overlooked, skill for effective allyship and fostering genuine inclusion, helping to close the gap between assumptions and understanding. By actively listening and resisting the urge to fill in gaps with preconceived notions, individuals can build stronger connections and create more equitable workplaces where everyone feels truly seen and heard.
Daily Mail
07-08-2025
- General
- Daily Mail
From 'queer theory' to 'guilt of being British' seminars, this is what really goes on inside the heart of government - and why it tells us this sad truth about the nation: RICHARD LITTLEJOHN
Today's edition of Makes You Proud To Be British comes courtesy of His Majesty's Revenue and Customs. Civil servants at HMRC this week were invited to a seminar during office hours on the 'Guilt of being British'. Those who'd actually bothered turning up at the office, that is.
Yahoo
25-06-2025
- Health
- Yahoo
Join the July 3 2025 Online Course on Sustainable Medical Device Design & Manufacture
Join this seminar to explore sustainable strategies in medical technology. Discover options, benefits, and drivers, and learn how to implement change for your company. Gain practical advice, assess risk, and develop achievable strategies. Earn 6 CPD hours and a certificate of completion. Dublin, June 25, 2025 (GLOBE NEWSWIRE) -- The "Sustainable Design and Manufacture for Medical Devices Training Course (ONLINE EVENT: July 3, 2025)" has been added to offering. Sustainability in medical technology, as in all industries, is increasingly no longer an option. It's not a question of "if" - it's a question of "how". This seminar will give you an in depth understanding of what sustainability options exist, what the benefits are, what drives them and how to choose which will work for your company. It will also provide practical advice on how to implement change. Benefits of attending Gain an understanding of how sustainability objectives can be made to fit with YOUR organisation and what you should be aiming to achieve Learn how to assess risk and develop a strategy that delivers worthwhile results in a realistic timeframe Appreciate where to start, how to manage change and how to justify the investment by measuring improvements Certifications: CPD: 6 hours for your records Certificate of completion Who Should Attend: Medical industry leaders Sustainability leaders Product owners Manufacturing managers Design heads Business development managers Anyone interested in sustainable design and manufacture Course Agenda: Background Focus: where does sustainable design and manufacture fit into the overall sustainability picture? What are the drivers for sustainability in YOUR industry/organisation? What are the barriers? What has your organisation done so far and why? Did it work? If not, why not? Understanding how to move forward Stakeholders in sustainable design and manufacture Risks - organisational, technical, regulatory and market Understanding the synergy between design, manufacture and remanufacture Planning change Appetite for change - selling the idea, getting stakeholders on board and assessing future market acceptance/demands Understanding the benefits - how sustainability can add value to your organisation and your products Sharing the vision and getting commitment/support Understanding risk - acknowledging that this is new ground and identifying what you don't know you don't know Planning phased implementation - disruptive change and how to manage it Feasibility analysis - the answer to the question "should we adopt sustainable manufacture" - might be no! Implementing change Where to start - design, manufacture, remanufacture or all three? How to "do" sustainable design. How have others done it? What can we learn? How suitable is it for medical? How to implement a recovery and remanufacturing loop. What can we learn from other industries? What external forces exist and how do we address them? Where to find support and how to keep the regulators happy Starting small and working up - balancing risk with manageable rates of progress and measuring success Scaling up, managing expectations and finding the optimum rate of change Making the financial case - how does sustainability pay for itself? Q&A and key takeaways For more information about this training visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo
24-06-2025
- Business
- Yahoo
FDA Regulatory Compliance for Drug and Biotech Products - 2 Day Virtual Training Course, July 16-17, 2025: Enhance Compliance Skills with Expert-Led Training and Resources
Enhance your regulatory compliance skills with a comprehensive course on FDA regulations for biologics and drug development. Learn practical applications for ensuring compliance with the FD&C Act and GMP regulations in drug manufacturing and testing. Attendees receive presentation slides, a participation certificate, a Q&A session, and free compliance handouts. Dublin, June 24, 2025 (GLOBE NEWSWIRE) -- The "FDA Regulatory Compliance for Drug and Biotech Products (ONLINE EVENT: July 16-17, 2025)" training has been added to offering. Enhance your knowledge of Regulatory Compliance with this specialized live seminar focused on the essential practices mandated by the Federal Food, Drug, and Cosmetic Act. Dive into the practical applications necessary for ensuring adherence to FDA regulations in biologics and drug development, a critical component for both sponsors and regulatory agencies. This seminar offers an insightful exploration of the graded approach in compliance, vital for pharmaceutical and biotechnology companies striving to meet Good Manufacturing Practice (GMP) regulations effectively. This includes the meticulous management needed in manufacturing, testing, and controlling clinical supplies, as well as overseeing commercial product outputs. This live training Seminar includes the following for each registered attendee: A copy of the presentation slides by download A certificate of participation for attendee training records Q/A Session Free Handouts on FDA Regulatory Compliance This course will benefit professionals involved in working with pharmaceutical and Biotech products and management involved in drug development and FDA Regulatory Compliance: QA/QC analytical chemists QA/QC directors, managers Investigators in QA/QC Manufacturing/Production Research and Development Project management Manufacturing personnel CROs analysts Technical liaison Regulatory affairs personnel CMC specialists Senior quality managers Quality professionals Regulatory professionals Compliance professionals Quality auditors Document control specialists New hires, as well as Managers, Directors, and Vice Presidents of Regulatory Affairs and Quality Assurance. Course Agenda: Day 1 FDA and its Statutory and Regulatory Requirements FDA's Structure and Purpose The Federal Food, Drug and Cosmetic Act The Code of Federal Regulations Guidane, Policy Documents and Compliance Manuals The Evolution of FDA Law Brief Overview: The Products FDA Regulates and Their Pathways to Market Drugs Medical Devices Food & Dietary Supplements Cosmetics Tobacco Veterinary Products Universal Requirements Establishment Registration, Product Listing, User Fees, etc. FDA Drug Development and Approval Process Considerations Statutory and Regulatory Provisions Citizen Petitions Approvals and Clearances The Drug IND, NDA, ANDA and Orphan Designation Biologic's BLA Medical Device 510(k) and PMA Combination Products Veterinary INAD, NADA, ANADA, MUMS FDA Drug Approval Process Case Study # 1: Suitability Petitions Case Study #2: Paragraph IV Certification Post Approval Submissions QbD product development and design Key elements of IND, NDA/ANDA applications and FDA expectations Electronic CTD format and content, most submitted through ESG (Electronic Submissions Gateway) Post approval changes to process, methods etc. Regulatory Filings Risk analysis Statutory and Regulatory Compliance The Concepts of "Adulteration" and "Misbranding" Identifying Non-Compliance Product Label and Labeling The Internet Approval and Clearance Facility Inspections Adverse Events Recalls Trade Complaints and Anonymous Tips FDA's Compliance Options, Historical Case Examples & FDA's Website Form 483s Untitled Letters Warning Letters Import Alerts Seizures Recalls Consent Decrees Temporary and Permanent Injunctions Civil and Criminal Prosecution The Park Doctrine Other Compliance Bodies DOJ, FTC, EPA, the States, NAD Management's Role and Responsibilities in Compliance Communication, Implementation and Decision Making Quality Policy and Resourcing Personnel Training Escalation of issues to upper management Corrective and Preventive Actions (CAPA) Gap Analysis Facility Audits and Inspections Internal Company Audits Training the Employees Use of Third-Party Auditors Auditor qualifications understanding Learn Key critical audit areas Internal auditing procedures and schedule Supplier and Customer Audits FDA Inspections Foreign Inspections The FDA Form 483 Strategies for Successfully Responding to a Form 483 including Inspection Observations and Violations The Written Response Communication with FDA Disagreements with Form 483 Observations When the Form 483 Becomes a Warning Letter Course Agenda Day 2 Manufacturing and Quality Controls for Drug Products Management's Role and Involvement Complying with Good Manufacturing Practices "cGMPs" Laboratory Quality Controls Standard Operating Procedures What Makes a Good SOP How to Write an Adequate SOP Strategies for Drafting Recalls and Market Withdrawals FDA Jurisdiction and Authority Stock Rotations Corrections Market Withdrawals Recalls Recall Classifications How to Conduct a Product Recall Customer Communication FDA Communication Documentation Strategies for Mitigating the Chances of a Recall Pharmacovigilance Definitions of Significant and Serious Adverse Events Recording, Investigating and Reporting Complaints FDA Communication Strategies for Dealing with Complaints Customs, Detentions and Import Alerts The Process Holds and Detentions Seizure and Destruction Remediating The Import Alert Rx Drug Promotion and Advertising Risk Considerations "Fair Balance" Elements & Considerations Brief Summary Boxed Warning Important Safety Information False and Misleading Claims Fair Balance Superiority Claims Testimonials Market Research Quality of Life Data Other Considerations Enforcement Action Examples Emerging Compliance Trends Counterfeit drug issues and growing concerns Drug shortage crisis Biosimilar approval pathways Others Other Compliance Issues Questions & Answers and Closing Thoughts For more information about this training visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Daily Mail
01-06-2025
- Business
- Daily Mail
Roxy Jacenko steps out wearing a staggering $1.5 MILLION worth of diamonds at Sydney speaking event
Roxy Jacenko flaunted her wealth on Friday as she stepped out at the Ivy Ballroom in Sydney for her In Conversation seminar. The PR maven, 45, decked herself out in diamonds as she attended the speaking event, ensuring she was the centre of attention in an angelic white dress. With her blonde tresses pulled back in an artful high pony, Roxy clasped a string of diamonds around her neck before adding glittering accessories, believed to be worth a staggering $1.5 million. She slipped on a gold Versace watch which retails for a jaw-dropping $2,320 and stood out against her white Simkhai mini dress worth $870. Roxy then stacked her other wrist with three bracelets - a gold and platinum bangle studded with gems, and a diamond chain, worth over a cool million all up. From A-list scandals and red carpet mishaps to exclusive pictures and viral moments, subscribe to the DailyMail's new showbiz newsletter to stay in the loop. The socialite completed her bejewelled look with simple diamond studs, a gold ring on one hand and her massive diamond wedding ring on the other. Roxy's lavish display comes after she slammed working from home arrangements, describing it as a 'lazy' work mentality. Speaking at her exclusive In Conversation event in Sydney, the PR dynamo said the key to a good business operation is interacting and networking - in person. 'We stopped picking up the phone, stopped going to things, stopped networking altogether. Zoom became an easy way of doing business,' Roxy told the crowd. 'It's a lazy way of doing business. The fact is, people want an experience, they want a memory. We need to start doing that networking again.' Roxy runs a PR firm and Ministry of Talent, a talent agency which represents influencers like Costeen Hatzi and reality TV star Ash Pollard. She believes as working from home arrangement continues, employees are increasingly forgetting the importance of being around people. 'Everything has become digital, but people want the touch-and-feel experience. This is why I am doing this (seminar), there is an importance in being around people,' she explained. The socialite completed her bejewelled look with simple diamond studs, a gold ring on one hand and her massive diamond wedding ring on the other 'We lost that connection during Covid. We became lazy. Instead of going to a face-to-face meeting you would have a meeting over Zoom or Teams.' 'I get to an end result because I do it face-to-face. People want to be treated like real people, they want to belong. It's about community,' she added. 'We want to see a familiar face, to see a connection. So much more comes from face-to-face than staring at a screen. It's s**t on Zoom, it doesn't have the same connection.' She went on to describe a recent business meeting with an investment banker in Singapore. When she walked into the company's office there were no employees at their desks because everyone was working from home. She said it made her think twice about working with the company, and in turn, they lost her business. 'When you walk into our MOT office, it's light and bright, there's orchards and music, There's a vibe!' she said. WFH became the norm for white-collar workers during the Covid lockdowns from 2020 - 2022, and has since become entrenched in many industries, with more than a third of Australians now doing their job at home. Some companies are pushing to get staff back into the office more often in the belief it is a more efficient way of working, but the Productivity Commission recently concluded the opposite.
